Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CSIRO Set to Commercialize New GI Technology - Nutraceuticals World

What are you searching for?

Sign in
Market Updates

CSIRO Set to Commercialize New GI Technology

Author Image

By: Sean Moloughney

Editor, Nutraceuticals World

The Australian Commonwealth Scientific and Research Organization (CSIRO) Food Futures Flagship has developed an automated instrument for accurately predicting glycemic index (GI) and resistant starch (RS) in food products. The prototype device is an in vitro (bench top) robotic machine that acts as an “artificial gut” to process large numbers of food samples at a fraction of the time and cost required by the standard in vivo (human) method. Its principal purpose is to help food manufacturers develop a wider range of healthy food products far more cheaply and quickly. The CSIRO validation program for the instrument has involved the testing of a range of commercial foods with a wide spectrum of GI and RS values. The results have been benchmarked against “gold standard” human-based tests on the same foods.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Add Nutraceuticals World as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters